Jones David Scott — SEC Form 4 filings
SEC reporting owner CIK 1779458. 6 Form 4 filings on record with FilingPulse; latest filed 2024-02-13.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-01-09 to 2024-02-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 4 filings — 73,192 shares, $1,759,138 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 33.
- Largest priced transaction: sale of 28,750 shares @ $22.69 ($652,254) in EyePoint Pharmaceuticals, Inc., filed 2024-01-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| EyePoint Pharmaceuticals, Inc. (EYPT) | SVP & Chief Commercial Officer | 6 | — | 11 legs · 73,192 sh · $1,759,138 | 33 |
Form 4 filings — Jones David Scott
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-02-13 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Option exercise (M): 4,967 @ $0 · Option exercise (M): 5,000 @ $0 · Tax withholding (F): 1,955 @ $28.80 · Tax withholding (F): 1,701 @ $28.80 · Option exercise (M): 4,967 (derivative) @ $0 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Option exercise (M): 209 @ $11.47 · Sale (S): 209 @ $28.49 · Option exercise (M): 209 (derivative) @ $0 | EDGAR |
| 2024-01-29 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Option exercise (M): 9,604 @ $12.90 · Option exercise (M): 16,413 @ $3.26 · Sale (S): 16,413 @ $25.45 · Sale (S): 9,604 @ $25.27 · Option exercise (M): 9,604 (derivative) @ $0 · Option exercise (M): 16,413 (derivative) @ $0 | EDGAR |
| 2024-01-26 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Option exercise (M): 5,600 @ $12.90 · Option exercise (M): 5,700 @ $3.26 · Sale (S): 5,700 @ $25.01 · Sale (S): 5,600 @ $25.01 · Option exercise (M): 300 @ $12.90 · Option exercise (M): 300 @ $3.26 · +6 more | EDGAR |
| 2024-01-24 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Option exercise (M): 28,750 @ $10.13 · Option exercise (M): 5,416 @ $11.47 · Sale (S): 5,416 @ $22.24 · Sale (S): 28,750 @ $22.69 · Option exercise (M): 400 @ $12.90 · Option exercise (M): 500 @ $3.26 · +6 more | EDGAR |
| 2024-01-09 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Option exercise (M): 15,285 @ $0 · Tax withholding (F): 4,147 @ $20.40 · Grant/award (A): 21,000 (derivative) @ $0 · Grant/award (A): 42,000 (derivative) @ $0 · Option exercise (M): 15,285 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1779458 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →